Literature DB >> 14704344

Echinomycin inhibits chromosomal DNA replication and embryonic development in vertebrates.

Laurence G May1, Mark A Madine, Michael J Waring.   

Abstract

Echinomycin, a member of the quinoxaline family of antibiotics, is known to be a strong inhibitor of RNA synthesis which has been attributed to its ability to bind to double-helical DNA. Here we study the effect of echinomycin upon DNA replication using egg extracts and embryos from Xenopus laevis as well as cultured human cells. Evidence is presented that echinomycin interferes with chromatin decondensation, nuclear assembly and DNA replication. In the absence of transcription and translation, the drug specifically blocks DNA replication in both Xenopus sperm chromatin and HeLa cell nuclei in vitro. By contrast, replication of single-stranded DNA is not inhibited indicating that echinomycin acts by interacting with the DNA and not the replication elongation proteins of chromatin. The addition of the antibiotic to HeLa cells and X.laevis embryos results in anaphase bridges and cell death. Importantly, in X.laevis embryos injected with echinomycin at the two-cell stage the drug specifically inhibits the cell cycle prior to the onset of transcription, suggesting that quinoxaline antibiotics could exert anti- proliferative effects by inhibition of chromosomal DNA replication.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14704344      PMCID: PMC373276          DOI: 10.1093/nar/gkh166

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  34 in total

1.  The nuclear membrane prevents replication of human G2 nuclei but not G1 nuclei in Xenopus egg extract.

Authors:  G H Leno; C S Downes; R A Laskey
Journal:  Cell       Date:  1992-04-03       Impact factor: 41.582

2.  Cyclin/Cdk-dependent initiation of DNA replication in a human cell-free system.

Authors:  T Krude; M Jackman; J Pines; R A Laskey
Journal:  Cell       Date:  1997-01-10       Impact factor: 41.582

3.  Echinomycin: a bifunctional intercalating antibiotic.

Authors:  M J Waring; L P Wakelin
Journal:  Nature       Date:  1974-12-20       Impact factor: 49.962

4.  Breakdown of pulse-labeled ribonucleic acid in Bacillus megaterium, revealed by exposure to the antibiotics mithramycin, chromomycin, and nogalamycin.

Authors:  J Fok; M Waring
Journal:  Mol Pharmacol       Date:  1972-01       Impact factor: 4.436

5.  Visualising the dissociation of sequence selective ligands from individual binding sites on DNA.

Authors:  M C Fletcher; K R Fox
Journal:  FEBS Lett       Date:  1996-02-12       Impact factor: 4.124

6.  Breakdown of pulse-labeled ribonucleic acid and polysomes in Bacillus megaterium: actions of streptolydigin, echinomycin, and triostins.

Authors:  M Waring; A Makoff
Journal:  Mol Pharmacol       Date:  1974-03       Impact factor: 4.436

7.  Geminin deficiency causes a Chk1-dependent G2 arrest in Xenopus.

Authors:  Thomas J McGarry
Journal:  Mol Biol Cell       Date:  2002-10       Impact factor: 4.138

8.  Interaction of Hoechst 33258 and echinomycin with nucleosomal DNA fragments containing isolated ligand binding sites.

Authors:  Kris D Leslie; Keith R Fox
Journal:  Biochemistry       Date:  2002-03-12       Impact factor: 3.162

9.  A new antitumor agent: methyl sulfonium perchlorate of echinomycin.

Authors:  Y S Park; Y H Kim; S K Kim; S J Choi
Journal:  Bioorg Med Chem Lett       Date:  1998-04-07       Impact factor: 2.823

10.  The binding of echinomycin to deoxyribonucleic acid.

Authors:  S P Wakelin; M J Waring
Journal:  Biochem J       Date:  1976-09-01       Impact factor: 3.857

View more
  8 in total

1.  Antiamoebic properties of the actinomycete metabolites echinomycin A and tirandamycin A.

Authors:  Avelina Espinosa; Aaron M Socha; Erica Ryke; David C Rowley
Journal:  Parasitol Res       Date:  2012-07-05       Impact factor: 2.289

2.  Apocarotenoids: Emerging Roles in Mammals.

Authors:  Earl H Harrison; Loredana Quadro
Journal:  Annu Rev Nutr       Date:  2018-05-11       Impact factor: 11.848

3.  Modulating hypoxia-inducible transcription by disrupting the HIF-1-DNA interface.

Authors:  Nicholas G Nickols; Claire S Jacobs; Michelle E Farkas; Peter B Dervan
Journal:  ACS Chem Biol       Date:  2007-08-17       Impact factor: 5.100

4.  Electrochemical behavior of quinoxalin-2-one derivatives at mercury electrodes and its analytical use.

Authors:  Milan Zimpl; Jana Skopalova; David Jirovsky; Petr Bartak; Tomas Navratil; Jana Sedonikova; Milan Kotoucek
Journal:  ScientificWorldJournal       Date:  2012-04-30

5.  3-Carbamoylquinoxalin-1-ium chloride.

Authors:  James K Harper; Gary Strobel; Atta M Arif
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-12-10

6.  Encapsulation of echinomycin in cyclodextrin inclusion complexes into liposomes: in vitro anti-proliferative and anti-invasive activity in glioblastoma.

Authors:  Walhan Alshaer; Manar Zraikat; Amer Amer; Hamdi Nsairat; Zainab Lafi; Dana A Alqudah; Enas Al Qadi; Tasneem Alsheleh; Fadwa Odeh; Arwa Alkaraki; Malek Zihlif; Yasser Bustanji; Elias Fattal; Abdalla Awidi
Journal:  RSC Adv       Date:  2019-09-30       Impact factor: 4.036

7.  The UvrA-like protein Ecm16 requires ATPase activity to render resistance against echinomycin.

Authors:  Amanda Erlandson; Priyanka Gade; Inoka P Menikpurage; Chu-Young Kim; Paola E Mera
Journal:  Mol Microbiol       Date:  2022-05-30       Impact factor: 3.979

8.  Replication initiation complex formation in the absence of nuclear function in Xenopus.

Authors:  Liliana Krasinska; Daniel Fisher
Journal:  Nucleic Acids Res       Date:  2009-02-22       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.